Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy in Early Trials
Russia has unveiled a groundbreaking medical development with the announcement of Enteromix, an mRNA-based cancer vaccine that achieved 100% efficacy and safety in early clinical trials. Designed to combat colorectal cancer, the vaccine represents a major leap in oncology by offering personalized immunotherapy tailored to an individual’s tumor profile.
Worldwide Impact: Could replace harsh treatments like chemotherapy with safer, targeted immunotherapy.
For India
Challenges: cost, infrastructure, genomic profiling facilities, cold-chain storage, and regulatory approval.
Former India & Chennai Super Kings captain Mahendra Singh Dhoni has retired from the Indian…
The Mekedatu Dam Project is a proposal for building a balancing reservoir and drinking water…
Doctors at the All India Institute of Medical Sciences (AIIMS) in New Delhi have completed…
The Reserve Bank of India has cancelled Certificates of Registration (CoRs) of 49 NBFCs and…
Trust in Times of Crisis: The Story of a Citizens’ Relief Effort for the Pandemic…
The Indian Wholesale Price Index (WPI)-based inflation rate rise to the 12.29 percent in October…